| 1100 |
Centers for Disease Control and Prevention |
Html |
en |
Workers' Memorial Day - April 28, 2014 |
Workers' Memorial Day, observed on April 28, 2014, recognizes workers who died or suffered from exposures to hazards at work. In 2012, a total of 4,383 U.S. |
| CDC | 0.552941 |
| endorsement | 0.468375 |
| illnesses | 0.548586 |
| Human Services | 0.659475 |
| MMWR HTML versions | 0.67001 |
| U.S. Department | 0.653995 |
| work-related illness | 0.683984 |
| electronic PDF version | 0.658411 |
| work-related injuries | 0.974404 |
| additional information | 0.55445 |
| Prevention effectiveness | 0.548684 |
| Contact GPO | 0.575324 |
| commercial sources | 0.549753 |
| current prices | 0.544199 |
| nonfatal work-related injuries | 0.878391 |
| U.S. workers | 0.604377 |
| original paper copy | 0.66578 |
| new cases | 0.559093 |
| U.S. Government Printing | 0.675452 |
| original MMWR paper | 0.664717 |
| methods | 0.445716 |
| local government workers | 0.718737 |
| work-related fatalities | 0.720657 |
| Occupational Safety | 0.555155 |
|
| MMWR readers | 0.554881 |
| character translation | 0.542272 |
| productivity losses | 0.553533 |
| Oxford University Press | 0.677544 |
| Haddix AC | 0.550978 |
| National Institute | 0.564693 |
| format errors | 0.543399 |
| New York | 0.550673 |
| societal cost | 0.691565 |
| Health | 0.468808 |
| Teutsch SM | 0.575448 |
| typeset documents | 0.550107 |
| national surveillance systems | 0.99086 |
| private industry workers | 0.720004 |
| unpublished data | 0.559908 |
| trade names | 0.549864 |
| official text | 0.540489 |
| emergency departments | 0.55437 |
| non-CDC sites | 0.547719 |
| Corso PS | 0.556202 |
| medical costs | 0.551479 |
| economic evaluation | 0.55198 |
| electronic conversions | 0.53957 |
| printable versions | 0.535737 |
|
CLICK HERE |
| 4736 |
Centers for Disease Control and Prevention |
Html |
en |
Eastern Equine Encephalitis - Arboviral Diagnostic Testing |
Eastern Equine Encephalitis is a rare disease that is caused by a virus spread by infected mosquitoes.
|
| arbovirus activity increases | 0.755158 |
| initial results | 0.475105 |
| fatal cases | 0.479542 |
| CDC | 0.320276 |
| histopathology | 0.268133 |
| Microsphere-Based Immunoassay | 0.466658 |
| confirmatory testing | 0.443563 |
| virus-specific IgM | 0.598843 |
| APPROPRIATE STATE HEALTH | 0.644131 |
| final results | 0.447749 |
| state health department | 0.94534 |
| patient | 0.280121 |
| specimen receipt | 0.511579 |
| CSF | 0.299929 |
| Initial serological testing | 0.710934 |
| Laboratory diagnosis | 0.477449 |
| antibodies | 0.257283 |
| nucleic acid amplification | 0.723214 |
| immunohistochemistry | 0.268758 |
| area | 0.24686 |
| arboviral infections | 0.538003 |
|
| test results | 0.651322 |
| MIA | 0.251833 |
| epidemiologic history | 0.522521 |
| dates | 0.247121 |
| Instructions | 0.241315 |
| virus culture | 0.462514 |
| autopsy tissues | 0.502588 |
| DVBID Arbovirus Diagnostic | 0.798779 |
| hard copy | 0.441693 |
| Preliminary diagnosis | 0.501719 |
| places | 0.247164 |
| IgM capture ELISA | 0.78432 |
| diagnostic specimens | 0.457961 |
| activities | 0.246795 |
| location | 0.246642 |
| IgG ELISA | 0.530671 |
| state laboratories | 0.471293 |
| serum | 0.27277 |
| travel | 0.247077 |
| non-endemic country | 0.490728 |
|
CLICK HERE |
| 5517 |
Centers for Disease Control and Prevention |
Html |
en |
Propane - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5958 |
Centers for Disease Control and Prevention |
Html |
en |
Methyl ethyl ketone peroxide - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6544 |
Centers for Disease Control and Prevention |
Html |
en |
CDC and Dengue Research - Dengue Fever |
CDC Works For You 24/7 Protecting People - Working to Protect Against the Dangers of Dengue - Dengue, a painful and sometimes deadly viral disease transmitted by mosquitoes, threatens more than 3.5 billion people worldwide. Dengue is endemic in at least 100 countries in Southeast Asia, the Pacific Islands, the Caribbean, Central America, South America, and parts of Africa. As many as 100 million people become infected yearly, and nearly 500,000, mostly children, develop the potentially deadly dengue hemorrhagic fever. |
| study mosquito-borne viruses | 0.326577 |
| best way | 0.323989 |
| virology lab | 0.269779 |
| ongoing efforts | 0.258936 |
| mosquito-transmitted disease | 0.274399 |
| Dr. Harold Margolis | 0.314723 |
| Claire Huang | 0.26602 |
| vaccine adoption strategies | 0.406326 |
| CDC program | 0.282028 |
| vector-borne diseases | 0.350594 |
| opportunity | 0.210869 |
| dengue experts | 0.538989 |
| international meeting | 0.263998 |
| dengue vaccine | 0.974188 |
| Scientists | 0.212651 |
| successful vaccine | 0.387244 |
| unique strength | 0.273401 |
| vaccination | 0.211249 |
| Puerto Rico | 0.441347 |
| dengue vaccine development | 0.699192 |
| production | 0.212615 |
| largest research unit | 0.327905 |
| southern Taiwan | 0.267147 |
| dengue vaccine research | 0.724541 |
| major activity | 0.272016 |
|
| Dengue v2V | 0.591152 |
| epidemiologic | 0.213935 |
| world | 0.211683 |
| Dengue Branch | 0.623567 |
| introduction | 0.218812 |
| Public health aspects | 0.337484 |
| San Juan | 0.269035 |
| CSU | 0.229765 |
| agency | 0.212424 |
| economic impact | 0.262027 |
| epidemic dengue activity | 0.581051 |
| relevant venue | 0.260143 |
| disease. | 0.212657 |
| dengue virus research | 0.658411 |
| people | 0.210793 |
| Colorado State University | 0.321352 |
| master | 0.211439 |
| life-long passion | 0.266248 |
| co-chair | 0.216381 |
| major dengue outbreak | 0.618503 |
| DVBD | 0.211723 |
| catch-up immunization | 0.263102 |
| technical data | 0.26171 |
| decades | 0.212727 |
|
CLICK HERE |
| 9176 |
Centers for Disease Control and Prevention |
Html |
en |
Prostate Cancer Rates by Race and Ethnicity |
Prostate cancer statistics from CDC: incidence and mortality by race and ethnicity. |
| numbers | 0.421228 |
| invasive cancer sites | 0.598755 |
| NVSS | 0.424124 |
| cancer excludes basal | 0.603825 |
| genital organs | 0.500593 |
| number | 0.463046 |
| shows | 0.46358 |
| ethnic populations | 0.601836 |
| A/PI | 0.419389 |
| Asian/Pacific Islander men | 0.601713 |
| registry-specific data quality | 0.585333 |
| prostate cancer incidence | 0.680285 |
| highest rate | 0.519055 |
| Hispanic origin | 0.601906 |
| National Vital Statistics | 0.574286 |
| Behavior recode | 0.508481 |
| National Program | 0.502499 |
| incidence rate | 0.639841 |
| age groups | 0.601885 |
| Sources | 0.419304 |
| graph | 0.470666 |
| Census P25–1130 | 0.604088 |
| population coverage | 0.602983 |
| data quality | 0.590945 |
| persons | 0.477805 |
|
| situ cancers | 0.502546 |
| death rates | 0.658072 |
| U.S. standard population | 0.7643 |
| AI/AN | 0.419413 |
| ethnicity | 0.484815 |
| 100,000 | 0.462855 |
| skin | 0.43263 |
| USCS technical notes | 0.938698 |
| data quality criteria | 0.58474 |
| cancer registries | 0.606121 |
| potential differences | 0.596273 |
| Asian/Pacific Islander | 0.633069 |
| †Race categories | 0.599682 |
| *Rates | 0.437861 |
| National Cancer Institute | 0.607294 |
| caution | 0.509713 |
| disease | 0.421074 |
| black men | 0.583168 |
| urinary bladder | 0.501382 |
| End Results program | 0.595054 |
| squamous cell carcinomas | 0.597043 |
| U.S. population | 0.59581 |
| prostate cancer | 0.907235 |
| American Indian/Alaska Native | 0.795329 |
|
CLICK HERE |
| 9367 |
Centers for Disease Control and Prevention |
Html |
es |
Marco de trabajo para la diseminación de prácticas de promoción de la salud basadas en la evidencia |
CDC - Wide Page example description goes here |
| Cancer Society Workplace | 0.985922 |
|
|
CLICK HERE |
| 11299 |
Centers for Disease Control and Prevention |
Html |
en |
What U.S. Hospitals Need to Know to Prepare for Ebola Virus Disease - Conference Call August 5, 2014 | Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| impacted countries | 0.485042 |
| United States | 0.444016 |
| patients | 0.326601 |
| Ebola hemorrhagic fever | 0.809932 |
| U.S. hospitals | 0.457057 |
| updates | 0.323667 |
| steps | 0.331951 |
| American citizens | 0.454404 |
| COCA | 0.348577 |
|
| guidance | 0.329852 |
| recent Ebola virus | 0.821637 |
| West Africa | 0.551427 |
| U.S. healthcare facilities | 0.549834 |
| outbreak | 0.402273 |
| clinicians | 0.339802 |
| U.S. hospital | 0.433922 |
| possibility | 0.387737 |
|
CLICK HERE |
| 13741 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Severe Illness Associated withReported Use of Synthetic Cannabinoids - Mississippi, April2015 |
Amelia M. Kasper, MD1,2; Alison D. Ridpath, MD2; Justin K. |
| 1Epidemic Intelligence Service | 0.531269 |
| electronic medical records | 0.562031 |
| 7Mississippi State Department | 0.553642 |
| Mississippi Medical Center | 0.792986 |
| novel synthetic cannabinoids | 0.694875 |
| UMMC emergency department | 0.57475 |
| different synthetic cannabinoids | 0.71116 |
| cannabinoid receptor | 0.604977 |
| general inpatient services | 0.536039 |
| systolic blood pressure | 0.539426 |
| Health Alert Network | 0.589169 |
| law enforcement officials | 0.528387 |
| synthetic cannabinoid intoxication | 0.804745 |
| physical examination findings | 0.532932 |
| Mississippi emergency departments | 0.584308 |
| health care providers | 0.701973 |
| UMMC patient population | 0.564496 |
| previous medical history | 0.550803 |
| synthetic cannabinoids | 0.97955 |
| Amelia M. Kasper | 0.567138 |
| National Center | 0.532197 |
| 3Georgia Poison Center | 0.548707 |
| vital signs | 0.544867 |
| urine drug | 0.545758 |
|
| Environmental Health | 0.541365 |
| chromatography-quadrupole time-of-flight mass | 0.543086 |
| Mississippi State Medical | 0.59541 |
| patients | 0.612676 |
| Justin K. Arnold | 0.552662 |
| public health officials | 0.5578 |
| San Francisco | 0.603391 |
| medical service reports | 0.568134 |
| urine drug screen | 0.53593 |
| Severe Illness Associated | 0.583807 |
| clinical urine drug | 0.539404 |
| Alison D. Ridpath | 0.561553 |
| California San Francisco | 0.537105 |
| plant-based opioid agonist | 0.538365 |
| Mississippi State Department | 0.985309 |
| Patrick B. Kyle | 0.557974 |
| Mississippi Poison Control | 0.591935 |
| 5Mississippi Poison Center | 0.548531 |
| intensive care admission | 0.538425 |
| main psychoactive component | 0.533303 |
| Environmental Biomonitoring Laboratory | 0.5557 |
| clinical laboratory data | 0.552737 |
| intensive care services | 0.547569 |
|
CLICK HERE |
| 14075 |
Centers for Disease Control and Prevention |
Html |
en |
HAN Archive - 00385|Health Alert Network (HAN) |
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC). |
| ongoing transmission | 0.350118 |
| Zika virus | 0.953386 |
| areas | 0.350292 |
| CDC Health Advisory | 0.360303 |
| pregnant women | 0.429485 |
| state health departments | 0.429044 |
| World Health Organization | 0.358942 |
| -registered insect repellents | 0.342051 |
| dengue virus | 0.381349 |
| Zika virus disease | 0.612277 |
| fetal losses | 0.350751 |
| virus clinical disease | 0.412391 |
| Virus-specific neutralization testing | 0.345686 |
| possible congenital infection | 0.352946 |
| RT-PCR protocols | 0.350126 |
| Zika virus transmission | 0.502959 |
| laboratory-confirmed Zika virus | 0.412047 |
| maculopapular rash | 0.381214 |
| American Health Organization | 0.35861 |
| Zika virus laboratory | 0.424016 |
| Environmental Protection Agency | 0.342338 |
| healthcare providers | 0.481795 |
| CDC Health Alert | 0.365985 |
| United States | 0.395918 |
| Aedes species mosquitoes | 0.345535 |
|
| commercially available test | 0.343509 |
| Zika virus infection | 0.737514 |
| continental United States | 0.395386 |
| specific antiviral treatment | 0.343558 |
| local health department | 0.386855 |
| enhances health decisions | 0.346968 |
| local transmission | 0.466346 |
| critical health issues | 0.348395 |
| state health department | 0.354944 |
| yellow fever viruses | 0.344715 |
| acute onset | 0.379756 |
| current outbreak | 0.351829 |
| Zika virus infections | 0.526936 |
| virus disease cases | 0.490855 |
| chikungunya virus infection | 0.410895 |
| similar geographic distribution | 0.342599 |
| non-steroidal anti-inflammatory drugs | 0.343067 |
| bites | 0.334185 |
| Aedes albopictus mosquitoes | 0.350057 |
| laboratory diagnostic testing | 0.344266 |
| Zika virus IgM | 0.417592 |
| risk | 0.33966 |
| CDC Arbovirus Diagnostic | 0.350115 |
| Zika virus testing | 0.41686 |
|
CLICK HERE |